Clinical Trial Update: A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating AVE8062 in advanced soft tissue sarcoma after failure of anthracycline and ifosfamide has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• AVE8062

Snippet

Sponsor: Sanofi | Conditions: Sarcoma | Phase 3 | Status: COMPLETED